Vida Icon Vida Logo
  • Home
  • About Us
  • Team
  • Portfolio
  • News
  • Investors
  • Fellowship
  • Contact

Author mattadmin19

13 October 2018

Allogene Therapeutics Announces Pricing of Initial Public Offering

read more
2 October 2018

FierceBiotech names Kronos Bio as one of its “Fierce 15” Biotech Companies of 2018

read more
27 September 2018

Sutro Biopharma Announces $85.0 Million Initial Public Offering

read more
14 June 2018

Ernst & Young LLP announces Arie Belldegrun as Entrepreneur Of The Year

read more
4 June 2018

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

read more
  • Newer
  • 1
  • 2
  • 3
  • 4
  • Older

Tweets

Tweets by vidaventures

Transforming biomedical innovations into therapies

Make a meaningful difference in patients’ lives

© 2025 Vida Ventures, LLC

  • Home
  • About Us
  • Team
  • Portfolio
  • News
  • Investors
  • Fellowship
  • Contact
Top